Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy

被引:102
|
作者
Langendijk, JA
Slotman, BJ
van der Waal, I
Doornaert, P
Berkof, J
Leemans, CR
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Radiat Oncol, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Dept Maxillary Surg, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Dept Clin Epidemiol & Biostat, Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Med Ctr, Dept Otolaryngol Head & Neck Surg, Amsterdam, Netherlands
关键词
head and neck carcinoma; radiotherapy; prognostic factors; overall treatment time;
D O I
10.1002/cncr.21340
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. The objective of this study was to define different prognostic groups with regard to locoregional control (LRC) derived from recursive partitioning analysis (RPA). METHODS. Eight hundred one patients with squamous cell head and neck carcinoma underwent with primary surgery and received postoperative radiotherapy. For the definition of prognostic groups, the method of classification and regression trees was performed, including a large number of well known prognostic factors. RESULTS. The final model was composed of six prognostic factors for LRC, resulting in seven terminal nodes. RPA Class I (intermediate risk) consisted of 381 patients who had no N3 lymph nodes, free surgical margins (> 5 mm), and no extranodal spread (ENS). RPA Class 11 (high risk) consisted of 189 patients who had 1 positive lymph node with ENS or had T1, T2, or T4 tumors with close or positive surgical margins. RPA Class III (very high risk) consisted of 231 patients who had a N3 neck, 2 positive lymph nodes with ENS, or a T3 tumor with close or positive surgical margins. The 5-year LRC rate was 88%, 73% and 58%, in RPA Class 1, 11, and III, respectively (P < 0.0001). The hazard ratio (HR) relative to RPA Class I was 2.3 (95% confidence interval [95%CI], 1.5-3.6) for RPA Class II and 4.2 (95%CI, 2.8-6.1) for RPA Class III. CONCLUSIONS. The RPA classification scheme studied allowed for the clear definition of three prognostic groups with regard to LRC and OS. These groups may be useful in the design of future prospective, randomized studies investigating new treatment modalities.
引用
收藏
页码:1408 / 1417
页数:10
相关论文
共 50 条
  • [41] Has Survival for Patients with Squamous Cell Carcinoma of the Head and Neck Treated with Radiotherapy Improved Over Time?
    Abramowitz, M. C.
    Santos, E.
    Raez, L.
    Weed, D.
    Mahmoud, O.
    Sperry, J.
    Wright, J.
    Sargi, Z.
    Lally, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S426 - S426
  • [42] Postoperative chemoradiotherapy for head and neck squamous cell carcinoma
    Honma, Yoshitaka
    ANNALS OF ONCOLOGY, 2022, 33 : S441 - S441
  • [43] The effect of time from surgery to commencing adjuvant radiotherapy for patients with head and neck squamous cell carcinoma
    Price, J. M.
    Garcez, K.
    Hughes, C.
    Lee, L. W.
    Mistry, H. M.
    Motamedi-Ghahfarokhi, G.
    Price, G. J.
    West, C. M.
    Thomson, D. J.
    ORAL ONCOLOGY, 2025, 161
  • [44] Salvage surgery after head and neck squamous cell carcinoma treated with bioradiotherapy
    Rovira, Aleix
    Tornero, Jordi
    Oliva, Marc
    Taberna, Miren
    Montal, Robert
    Nogues, Julio
    Farre, Anna
    Lares, Henry
    Navarro, Valenti
    Mari, Antoni
    Maria Vinals, Joan
    Lozano, Alicia
    Mesia, Ricard
    Manos, Manel
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2017, 39 (01): : 116 - 121
  • [45] Radiotherapy or Surgery for Head and Neck Squamous Cell Cancer Establishing the Baseline for Hypopharyngeal Carcinoma?
    Hall, Stephen F.
    Groome, Patti A.
    Irish, Jonathan
    O'Sullivan, Brian
    CANCER, 2009, 115 (24) : 5711 - 5722
  • [46] SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - COMBINED THERAPY - SURGERY AND POSTOPERATIVE IRRADIATION
    MILLION, RR
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1979, 5 (11/1): : 2161 - 2162
  • [47] Head and Neck Squamous Cell Carcinoma in Elderly Patients: Role of Radiotherapy and Chemotherapy
    Fasano, Morena
    D'Onofrio, Ida
    Belfiore, Maria Paola
    Angrisani, Antonio
    Caliendo, Valentina
    Della Corte, Carminia Maria
    Pirozzi, Mario
    Facchini, Sergio
    Caterino, Marianna
    Guida, Cesare
    Nardone, Valerio
    Reginelli, Alfonso
    Cappabianca, Salvatore
    CANCERS, 2022, 14 (03)
  • [48] OUTCOMES OF POSTOPERATIVE SIMULTANEOUS MODULATED ACCELERATED RADIOTHERAPY FOR HEAD-AND-NECK SQUAMOUS CELL CARCINOMA
    Moon, Sung Ho
    Jung, Yuh-Seog
    Ryu, Jun Sun
    Choi, Sung Weon
    Park, Joo Yong
    Yun, Tak
    Lee, Sang Hyun
    Cho, Kwan Ho
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (01): : 140 - 149
  • [49] A PROSPECTIVE TRIAL OF ACCELERATED RADIOTHERAPY IN THE POSTOPERATIVE TREATMENT OF HIGH-RISK SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    TROTTI, A
    KLOTCH, D
    ENDICOTT, J
    RIDLEY, M
    GREENBERG, H
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 26 (01): : 13 - 21
  • [50] Potential Biomarkers for the locoregional Control of Head and Neck Squamous Cell Carcinoma after postoperative Radiotherapy
    Hiepe, H.
    Loeck, S.
    Appold, S.
    Nowak, A.
    Haim, D.
    Gudziol, V.
    Kemper, M.
    Baretton, G.
    Baumann, M.
    Krause, M.
    Linge, A.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S61 - S62